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Disruption of the developmentally regulated Rev3l gene causes
embryonic lethality
J. Wittschieben*, M.K.K. Shivji*, E. Lalani†, M.A. Jacobs*, F. Marini*,
P.J. Gearhart‡, I. Rosewell*, G. Stamp† and R.D. Wood*
The REV3 gene encodes the catalytic subunit of DNA
polymerase (pol) ζ, which can replicate past certain types
of DNA lesions [1]. Saccharomyces cerevisiae rev3
mutants are viable and have lower rates of spontaneous
and DNA-damage-induced mutagenesis [2]. Reduction in
the level of Rev31, the presumed catalytic subunit of
mammalian pol ζ, decreased damage-induced
mutagenesis in human cell lines [3]. To study the function
of mammalian Rev31, we inactivated the gene in mice.
Two exons containing conserved DNA polymerase motifs
were replaced by a cassette encoding G418 resistance
and β-galactosidase, under the control of the Rev3l
promoter. Surprisingly, disruption of Rev3l caused
mid-gestation embryonic lethality, with the frequency of
Rev3l–/– embryos declining markedly between 9.5 and
12.5 days post coitum (dpc). Rev3l–/– embryos were
smaller than their heterozygous littermates and showed
retarded development. Tissues in many areas were
disorganised, with significantly reduced cell density.
Rev3l expression, traced by β-galactosidase staining, was
first detected during early somitogenesis and gradually
expanded to other tissues of mesodermal origin,
including extraembryonic membranes. Embryonic death
coincided with the period of more widely distributed
Rev3l expression. The data demonstrate an essential
function for murine Rev31 and suggest that bypass of
specific types of DNA lesions by pol ζ is essential for cell
viability during embryonic development in mammals.
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Results and discussion
The targeting vector was designed to inactivate the predicted
polymerase activity of the Rev3l protein by eliminating
two exons encoding conserved polymerase motif V and
part of motif I [4]. These were replaced with a dicistronic
cassette containing lacZ fused to a neomycin-resistance
gene (Figure 1). Heterozygous intercrosses yielded only
Rev3l+/– and Rev3l+/+ progeny in a 2.3:1 ratio, demonstrat-
ing that disuption of the Rev3l polymerase domain results
in embryonic lethality (Table 1). Morphology, fertility and
viability of Rev3l+/– animals appeared normal, indicating
no influence of gene dosage and no dominant-negative
effect of any truncated protein that might be produced.
The non-viability of Rev3l–/– embryos was unexpected as
yeast with a deletion of REV3 show no growth defects, are
modestly sensitive to DNA damaging agents, and have
lower rates of induced and spontaneous mutations [2].
Furthermore, humans with a defect in pol η, another
DNA polymerase that bypasses damage, can live for
decades and show relatively mild symptoms [5,6].
To determine the developmental stage at which the poly-
merase disruption causes lethality, embryos from Rev3l+/–
intercrosses were analysed. Beginning at 10.5 dpc, the
fraction of embryos that were homozygous for the disrup-
tion became progressively lower (Table 1). At 7.5 dpc,
Rev3l–/– and Rev3l+/– embryos appeared equivalent in size
and developmental stage. From 8.5 dpc, Rev3l–/– embryos
were smaller than their heterozygous and wild-type litter-
mates. Between 9.5 dpc and 12.5 dpc, mutants were about
60% of the expected length and there was a developmen-
tal delay of up to 2 days, accompanied by defective mor-
phogenesis (Figure 2 and data not shown). Although
Rev3l–/– embryos had not turned by 9.5 dpc (Figure 2d),
some Rev3l–/– embryos did complete axial rotation by
Figure 1
Targeted disruption of the Rev3l gene. A targeting vector was
constructed by subcloning genomic sequences (blue) into pBluescript II
KS+. A promoterless cassette containing the splice acceptor from the
En-2 gene (En-2-SA), an internal ribosome entry site (IRES), lacZ–neoR
selection marker and a polyadenylation sequence (SV40pA) was
placed between the arms, replacing the indicated region including two
exons encoding amino acids 2776–2860 of Rev3l.
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10.5 dpc (Figure 2i). Head, abdominal and tail regions
formed, as did the neural tube, somite pairs, branchial
arches and limb buds (Figure 2). Rev3l–/– embryos could
be distinguished readily by their craniofacial and abdomi-
nal abnormalities. For example, at 9.5 and 10.5 dpc, the
somites in Rev3l–/– embryos had a diffuse, irregular struc-
ture and were fewer in number than in heterozygous lit-
termates (Figure 2).
Rev3l–/– embryos with beating heart structures containing
blood were visible until the latest time of viability, but
pericardial sac edema was commonly observed at later
stages (Figure 2i). Blood within yolk sac vasculature was
also observed in Rev3l–/– embryos, although the vessels
were less branched than in their heterozygous and wild-
type littermates. The yolk sacs of Rev3l–/– embryos were
often fragile, with loose attachment of the embryo to the
decidual implantation site, possibly because of delayed
and/or suboptimal chorioallantoic fusion. Abnormalities in
the development and maintenance of embryonic meso-
derm were major features associated with disruption of
Rev3l. Mesenchyme from Rev3l–/– embryos was often dis-
cohesive and degenerate, with pyknotic bodies and debris
visible throughout the tissue, although occasional mitotic
figures were still seen (Figure 3). Nucleated red blood
cells indicative of embryonic hemopoeisis were abundant
in the Rev3l–/– embryos (Figure 3b). Abnormalities were
not confined to tissues of mesodermal origin. Epithelial
and neuroepithelial cell pleomorphism was also commonly
seen, possibly a consequence of discohesion and degener-
ation of the surrounding mesenchyme (Figure 3c). Attempts
to generate embryonic fibroblasts from such Rev3l–/–
mid-gestation embryos have been unsuccessful. 
The targeting strategy enabled us to monitor expression
from the Rev3l promoter by staining embryos for β-galactosi-
dase activity. Expression of Rev3l was first detectable within
the earliest somite pairs formed at 7.5–8.0 dpc (Figure 2j)
and continued during further somitogenesis. From 9.5 dpc,
the lacZ transgene was expressed within the developing
myocytes of the heart and in the mesenchyme close to the
aorta (Figure 4d). At 10.5 dpc, strong expression of Rev3l
was found in the peri-optic mesenchyme surrounding the
optic vesicle (Figure 4a). This striking increase in expression
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Figure 2
Rev3l expression in mouse embryos at (a–e) 9.5 dpc and
(f–i,k) 10.5 dpc and (j) 7.5 dpc. (j) At 7.5–8.0 dpc, expression was
seen in the somites (so). The neural folds (nf) are indicated. The
10.5 dpc embryo and its implantation site are shown in (k); al, allantoic
mesenchyme; ch, chorion; um, umbilicus. Rev3l+/– mice were mated
and pregnant females sacrificed. Embryos were dissected from their
yolk sacs, washed in phosphate-buffered saline, fixed and stained with
X-gal. Length of embryos from head to tail: Rev3l+/– 9.5 dpc, 2.5 mm;
Rev3l–/– 9.5 dpc, 1.5 mm; Rev3l+/– 10.5 dpc, 3.5 mm; Rev3l–/–
10.5 dpc, 2–2.5 mm.
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Table 1
Embryos and progeny from Rev31+/– intercrosses.
Number per
Age genotype
(dpc)                               Total number +/+ +/– –/–
7.5 7 1 4 2
8.5 9 3 4 2
9.5 3 0 2 1
9.5 11 3 5 3
9.5 12 2 4 6
Total 9.5 26 5 11 10
10.5 5 3 2 0
10.5 6 0 4 2
10.5 5 3 1 1
10.5 10 3 7 0
10.5 8 2 5 1
10.5 14 5 5 4
Total 10.5 48 16 24 8
11.5 10 5 4 1
11.5 9 2 5 2
Total 11.5 19 7 9 3
12.5 6 2 4 0
12.5 5 4 1 0
12.5 6 3 3 0
12.5 7 2 4 1
Total 12.5 24 11 12 1
Mice born 164 50 114 0
Timed matings were set up and the day on which the copulation plug
was found was designated as 0.5 dpc. Embryos were explanted and
dissected away from fetal membranes. Yolk sacs were washed in
phosphate-buffered saline and frozen on dry ice. DNA was extracted
from the yolk sacs of embryos or tail snips of 14-day-old mice using a
Qiagen DNeasy Tissue Kit. PCR genotyping is described in the
Supplementary materials and methods.
in the peri-optic region occurred between 9.5 and 10.5 dpc
(compare Figure 2b with Figure 2f,g). Some expression was
also detected in retroperitoneal mesenchyme and in mes-
enchyme surrounding dorsal root ganglia (Figure 4b and
data not shown). Dark mid-ventral staining was detected in
whole mounts (Figure 2b,d,f,i). Some of this was accounted
for by staining in and near the heart, but additional strong
expression was found near the fourth branchial arch and in
thyroid precursor mesenchyme near the lung bud
(Figure 4c). The staining of tissues in Rev3l–/– embryos was
generally more diffuse (Figure 2d,e,h,i) and is likely to be
the result of the marked disorganisation and cell loss in
tissues often found in the homozygous mutants. Areas of
β-galactosidase staining could be found within such degen-
erated tissue (Figure 3c,d).
In adult tissues, Rev3l expression has been examined by
northern blotting in mouse [7] and by reverse transcription
coupled to PCR (RT–PCR) of human DNA [8]. Some
expression was detected in all tissues examined, including
those predominantly derived from ectoderm (brain), endo-
derm (lung) and mesoderm (muscle). Our results indicate
that high-level expression of Rev3l is developmentally
regulated during embryogenesis, occurring first in early
somitogenesis and then in other mesodermal tissues up to
at least 11.5 dpc. This differential expression seems likely
to account for the predominant disorder and lack of
integrity found mainly in mesenchymal tissues. Lack of
proper development of the heart and large circulatory
vessels might in itself be the immediate cause of death.
To examine whether Rev3l is expressed within extraem-
bryonic membranes, decidua were partially dissected to
observe implanted embryos. In heterozygous and homozy-
gous mutants, β-galactosidase activity was observed within
the amnion, allantoic mesenchyme and major blood
vessels of the umbilical cord (Figure 2k). These tissues
are partially or wholly derived from mesoderm. Neverthe-
less, Rev3l expression was not detectable within all
extraembryonic tissues, as the chorion beneath the allan-
toic mesoderm appeared unstained. As Rev3l is normally
expressed within extraembryonic membranes, the absence
of functional Rev3l in Rev3l–/– embryos could be the cause
of the pericardial sac edema, yolk sac fragility and weak
attachment to the decidual implantation site. Yolk-sac
malfunction can induce osmotic imbalance, leading to
edema, whereas delayed and/or suboptimal chorioallantoic
fusion could result in an implantation defect. Defects of
the chorioallantoic placenta or yolk sac are a common
cause of murine lethality in utero [9] and could contribute
to the embryonic lethality of the Rev3l disruption.
Unexpectedly, disruption of the polymerase domain of
Rev3l causes loss of embryonic viability between 9.5 and
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Figure 3
Mesenchymal degeneration in Rev3l–/– embryos. Embryos (10.5 dpc)
were stained for β-galactosidase activity, fixed and embedded. Sections
shown were stained with haematoxylin and eosin. (a) Cephalic region of
Rev3+/+ embryo showing normal tissue density in mesenchyme (me)
and epithelium (ep) and absence of dying cells. (b) Degenerated gut
mesenchyme in Rev3–/– embryos. The large cells seen in the centre are
nucleated red blood cells (rbc). (c) Highly disorganised and
degenerated mesenchyme in a Rev3l–/– embryo. Degenerated neural
tube tissue (nt) is also indicated. (d) Higher power oil immersion view
of a lower right section of (c). Small arrows, examples of staining with
X-gal; arrowheads, examples of pyknotic nuclei.
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Figure 4
Differential expression of Rev3l in tissues from embryos at
(a,b,d) 11.5 dpc and (c) 10.5 dpc. The embryos were processed as
in Figures 2 and 3. Only Rev3l+/– and Rev3l–/– embryos exhibited
β-galactosidase staining. (a) Polar mesenchymal expression in the
region around the optic vesicle (ov) of a Rev3l+/– embryo. (b,c) Staining
in the mesenchyme (me) around (b) a posterior root ganglion (ga) and
(c) the fourth branchial arch (arrow) adjacent to the dorsal aorta in
Rev3l+/– embryos. (d) Expression in myocytes in the developing heart of
a Rev3l–/– embryo, showing some disorder of mesenchymal tissue.
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12.5 dpc. The expression pattern of Rev3l suggests a
crucial role of this protein in mesodermal tissues of
embryonic and/or extraembryonic origin. If this role is not
fulfilled, there is degeneration and cell loss throughout
the embryo. How does Rev3l prevent cell death? There
are several hints from the phenotype of yeast rev3 mutants
and the activity of the gene product. First, yeast rev3
mutants are defective in damage-induced mutagenesis [2].
This appears to be a direct consequence of the fact that
DNA pol ζ has the ability to bypass certain types of DNA
damage, and in the process often inserts a non-comple-
mentary nucleotide. Lack of pol ζ causes yeast cells to be
only slightly sensitive to killing by ultraviolet light. This
probably indicates that other DNA repair and lesion
bypass processes in yeast can combat most of the mutagen
toxicity in the absence of pol ζ, but that pol ζ is still the
main enzyme used for bypass in some situations. A second
role for pol ζ is indicated by experiments which show that
one pathway of double-strand break repair in S. cerevisiae
normally makes use of pol ζ, as indicated by a Rev3-
dependent pattern of mutations introduced in the vicinity
of the break site during repair [10].
The Rev3l-defective mouse embryos studied here arose
from zygotes that were able to propagate and differentiate
through many cell divisions before embryonic death.
During this time, the rapidly proliferating cells in the
embryo might gradually accumulate DNA damage that in
normal organisms is bypassed by pol ζ. Numerous DNA
lesions caused by unavoidable oxidative and hydrolytic
processes are constantly formed in genomes [11]. Similarly,
double-strand breaks can form when DNA replication forks
encounter nicked templates, and these stalled replication
forks must be reactivated by replication or repair. Cells in
adult tissues or in culture have mechanisms to cease divi-
sion or DNA replication temporarily in order to allow time
for accurate and specific DNA repair enzymes to act before
proceeding through the cell cycle. However, embryonic
development adheres to a strict temporal programme that
requires rapid cell division. Under such conditions, enzymes
that can rapidly bypass DNA lesions may be expected to be
particularly important. We have been unable to isolate
homozygous Rev3l–/– ES cells by culturing Rev3l+/– ES cells
in high G418 concentrations or by retargeting Rev3l+/– cells
with a disruption construct conferring hygromycin resis-
tance. ES cells may be a special case of a cell type primed to
undergo apoptosis after accumulating low levels of DNA
damage [12]. We have, however, been unable so far to
obtain live homozygous progeny by crossing the Rev3l
defect onto a p53-defective background. The mesodermal
tissues in which Rev3l is most highly expressed may have a
special need for the polymerase activity of pol ζ if certain
types of DNA adducts or strand breaks accumulate in them.
An intolerable load of damaged DNA in critical embryonic
or extra-embryonic cells would then lead to death. It is also
possible that Rev3l has an additional, unknown function.
Supplementary material
A figure showing more details of the targeting construct, additional dis-
cussion and methodological detail are available at http://current-
biology.com/supmat/supmatin.htm.
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